DTIL

SEC source: 0001209191-21-012745 · doc4.xml · nonDerivative · entry 2

KANE MATTHEW R. · CIK 0001769887 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,889,446

F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares.

SEC source: 0001209191-21-012745 · doc4.xml · nonDerivative · entry 1

KANE MATTHEW R. · CIK 0001769887 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,899,151

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-011888 · doc4.xml · derivative · entry 7

KANE MATTHEW R. · CIK 0001769887 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,140

Underlying: Common Stock · 21,514 shares

Expires 2021-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001209191-21-011888 · doc4.xml · nonDerivative · entry 4

KANE MATTHEW R. · CIK 0001769887 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,877,637

F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares.

SEC source: 0001209191-21-011888 · doc4.xml · nonDerivative · entry 3

KANE MATTHEW R. · CIK 0001769887 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,887,342

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-011888 · doc4.xml · derivative · entry 6

KANE MATTHEW R. · CIK 0001769887 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 236,654

Underlying: Common Stock · 21,514 shares

Expires 2021-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001209191-21-011888 · doc4.xml · nonDerivative · entry 2

KANE MATTHEW R. · CIK 0001769887 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,865,828

F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares.

SEC source: 0001209191-21-011888 · doc4.xml · nonDerivative · entry 1

KANE MATTHEW R. · CIK 0001769887 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,875,525

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-006831 · doc4.xml · derivative · entry 3

JANTZ DEREK · CIK 0001769828 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 258,168

Underlying: Common Stock · 21,515 shares

Expires 2021-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001209191-21-006831 · doc4.xml · nonDerivative · entry 2

JANTZ DEREK · CIK 0001769828 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,907,345

F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares.

SEC source: 0001209191-21-006831 · doc4.xml · nonDerivative · entry 1

JANTZ DEREK · CIK 0001769828 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,913,789

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-006128 · doc4.xml · derivative · entry 6

JANTZ DEREK · CIK 0001769828 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 279,683

Underlying: Common Stock · 21,514 shares

Expires 2021-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001209191-21-006128 · doc4.xml · nonDerivative · entry 4

JANTZ DEREK · CIK 0001769828 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,892,274

F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares.

SEC source: 0001209191-21-006128 · doc4.xml · nonDerivative · entry 3

JANTZ DEREK · CIK 0001769828 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,898,718

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-006128 · doc4.xml · derivative · entry 5

JANTZ DEREK · CIK 0001769828 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 301,197

Underlying: Common Stock · 21,514 shares

Expires 2021-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001209191-21-006128 · doc4.xml · nonDerivative · entry 2

JANTZ DEREK · CIK 0001769828 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,877,204

F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares.

SEC source: 0001209191-21-006128 · doc4.xml · nonDerivative · entry 1

JANTZ DEREK · CIK 0001769828 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,884,252

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-005870 · doc4.xml · derivative · entry 4

KANE MATTHEW R. · CIK 0001769887 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 258,168

Underlying: Common Stock · 21,515 shares

Expires 2021-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001209191-21-005870 · doc4.xml · nonDerivative · entry 2

KANE MATTHEW R. · CIK 0001769887 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,854,011

F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.33 to $13.47. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-21-005870 · doc4.xml · nonDerivative · entry 1

KANE MATTHEW R. · CIK 0001769887 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,863,708

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-005395 · doc4.xml · derivative · entry 7

KANE MATTHEW R. · CIK 0001769887 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 279,683

Underlying: Common Stock · 21,514 shares

Expires 2021-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001209191-21-005395 · doc4.xml · nonDerivative · entry 4

KANE MATTHEW R. · CIK 0001769887 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,842,193

F2 · kind: The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise for an option grant expiring 05/17/2021, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.70 to $13.86. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-21-005395 · doc4.xml · nonDerivative · entry 3

KANE MATTHEW R. · CIK 0001769887 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,851,888

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-005395 · doc4.xml · derivative · entry 6

KANE MATTHEW R. · CIK 0001769887 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 301,197

Underlying: Common Stock · 21,514 shares

Expires 2021-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The option is fully vested and exercisable.

SEC source: 0001209191-21-005395 · doc4.xml · nonDerivative · entry 2

KANE MATTHEW R. · CIK 0001769887 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,830,374

F2 · kind: The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise for an option grant expiring 05/17/2021, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.50 to $13.60. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-21-005395 · doc4.xml · nonDerivative · entry 1

KANE MATTHEW R. · CIK 0001769887 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,840,592

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 6,651 additional shares acquired under the Company's 2019 Employee Stock Purchase Plan since the reporting person's ownership report filed on September 25, 2019.

SEC source: 0001209191-21-005016 · doc4.xml · nonDerivative · entry 1

THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,243

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · balance_after: Includes 2,130 additional shares acquired under the Company's 2019 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on June 12, 2019.

SEC source: 0001209191-22-016629 · doc4.xml · nonDerivative · entry 2

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,228

SEC source: 0001209191-21-039902 · doc4.xml · derivative · entry 1

KANE MATTHEW R. · CIK 0001769887 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 1,743

Underlying: Common Stock · 1,743 shares

Expires 2030-08-20

F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares on April 1, 2021 and thereafter in twelve equal installments at the end of each three-month period over the 36 months following such date.

F2 · ownership.nature: Employee Stock Option is held by Chelsea Lynam Kane, the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

SEC source: 0001209191-20-037218 · doc4.xml · derivative · entry 2

ANSARI ABID · CIK 0001770149 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,785

Underlying: Common Stock · 8,783 shares

Expires 2026-08-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option vested as to 25% of the underlying shares on August 11, 2017 and vests in equal installments at the end of each successive three month period over the 36 months following such date.

SEC source: 0001209191-20-037218 · doc4.xml · nonDerivative · entry 1

ANSARI ABID · CIK 0001770149 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 144,401

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-035584 · doc4.xml · derivative · entry 1

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,424

Underlying: Common Stock · 108,424 shares

Expires 2030-06-07

F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares on April 1, 2021 and vests in equal installments at the end of each successive three-month period over the 36 months following such date.

SEC source: 0001209191-20-035591 · doc4.xml · derivative · entry 1

KANE MATTHEW R. · CIK 0001769887 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 202,391

Underlying: Common Stock · 202,391 shares

Expires 2030-06-07

F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares on April 1, 2021 and vests in equal installments at the end of each successive three-month period over the 36 months following such date.

SEC source: 0001209191-20-035570 · doc4.xml · derivative · entry 1

ANSARI ABID · CIK 0001770149 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,141

Underlying: Common Stock · 112,141 shares

Expires 2030-06-07

F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares on April 1, 2021 and vests in equal installments at the end of each successive three-month period over the 36 months following such date.

SEC source: 0001209191-20-035589 · doc4.xml · derivative · entry 1

JANTZ DEREK · CIK 0001769828 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,109

Underlying: Common Stock · 130,109 shares

Expires 2030-06-07

F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares on April 1, 2021 and vests in equal installments at the end of each successive three-month period over the 36 months following such date.

SEC source: 0001209191-20-035586 · doc4.xml · derivative · entry 1

KHAZI FAYAZ · CIK 0001770314 · CEO of Elo Life Systems

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,391

Underlying: Common Stock · 107,391 shares

Expires 2030-06-07

F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares on April 1, 2021 and vests in equal installments at the end of each successive three-month period over the 36 months following such date.

SEC source: 0001209191-20-035569 · doc4.xml · derivative · entry 1

Heery Christopher · CIK 0001789632 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,206

Underlying: Common Stock · 133,206 shares

Expires 2030-06-07

F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares on April 1, 2021 and vests in equal installments at the end of each successive three-month period over the 36 months following such date.

SEC source: 0001209191-20-035568 · doc4.xml · derivative · entry 1

THOMSON DAVID S. · CIK 0001770315 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,891

Underlying: Common Stock · 154,891 shares

Expires 2030-06-07

F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares on April 1, 2021 and vests in equal installments at the end of each successive three-month period over the 36 months following such date.

SEC source: 0001209191-20-030319 · doc4.xml · derivative · entry 4

ANSARI ABID · CIK 0001770149 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,514

Underlying: Common Stock · 878 shares

Expires 2027-03-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested as to 25% of the underlying shares on March 24, 2018 and vests in equal installments at the end of each successive three month period over the 36 months following such date.

SEC source: 0001209191-20-030319 · doc4.xml · derivative · entry 3

ANSARI ABID · CIK 0001770149 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,568

Underlying: Common Stock · 8,783 shares

Expires 2026-08-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the underlying shares on August 11, 2017 and vests in equal installments at the end of each successive three month period over the 36 months following such date.

SEC source: 0001209191-20-030319 · doc4.xml · nonDerivative · entry 2

ANSARI ABID · CIK 0001770149 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,618

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 2,112 additional shares acquired under the Company's 2019 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on January 8, 2020.

SEC source: 0001209191-20-030319 · doc4.xml · nonDerivative · entry 1

ANSARI ABID · CIK 0001770149 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,740

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 2,112 additional shares acquired under the Company's 2019 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on January 8, 2020.

SEC source: 0001209191-20-029691 · doc4.xml · derivative · entry 1

Buehler Kevin · CIK 0001792722 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,038

Underlying: Common Stock · 41,038 shares

Expires 2030-05-12

F1 · derivative.exercise_date: The option vests on the earlier of May 13, 2021 or the day immediately prior to the date of the next annual meeting of the Company's stockholders occurring after May 13, 2020.

SEC source: 0001209191-20-029690 · doc4.xml · derivative · entry 1

Sharp Shalini · CIK 0001377202 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,038

Underlying: Common Stock · 41,038 shares

Expires 2030-05-12

F1 · derivative.exercise_date: The option vests on the earlier of May 13, 2021 or the day immediately prior to the date of the next annual meeting of the Company's stockholders occurring after May 13, 2020.

SEC source: 0001209191-20-029688 · doc4.xml · derivative · entry 1

Schinazi Raymond F · CIK 0001397607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,038

Underlying: Common Stock · 41,038 shares

Expires 2030-05-12

F1 · derivative.exercise_date: The option vests on the earlier of May 13, 2021 or the day immediately prior to the date of the next annual meeting of the Company's stockholders occurring after May 13, 2020.

SEC source: 0001209191-20-024509 · doc4.xml · derivative · entry 2

JANTZ DEREK · CIK 0001769828 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,854

Underlying: Common Stock · 4,392 shares

Expires 2027-03-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option vested as to 25% of the underlying shares on March 24, 2018 and vests in equal installments at the end of the each successive three-month period over the 36 months following such date.

SEC source: 0001209191-20-024509 · doc4.xml · nonDerivative · entry 1

JANTZ DEREK · CIK 0001769828 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,862,738

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-018527 · doc4.xml · derivative · entry 1

Germano Geno J · CIK 0001424383 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,776

Underlying: Common Stock · 71,776 shares

Expires 2030-03-09

F1 · derivative.exercise_date: The option vests over 3 years in 36 substantially equal monthly installments following March 10, 2020.

SEC source: 0001209191-22-016629 · doc4.xml · nonDerivative · entry 1

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,072

SEC source: 0001209191-20-002445 · doc4.xml · derivative · entry 4

ANSARI ABID · CIK 0001770149 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,392

Underlying: Common Stock · 2,634 shares

Expires 2027-03-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the underlying shares on March 24, 2018 and vests in equal installments at the end of each successive three-month period over the 36 months following such date.